Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (02566) disclosed a Next Day Disclosure Return. As of 4 February 2026, there were 106,528,185 issued ordinary H shares excluding treasury shares, plus 2,568,600 treasury shares, for a total of 109,096,785 shares.

On 5 February 2026, a repurchase of 854,000 H shares was reported, conducted on the Hong Kong Stock Exchange. These repurchased shares were transferred to treasury, raising the treasury shareholding to 3,422,600 and reducing the number of issued shares excluding treasury shares to 105,674,185. The total number of shares in issue remained 109,096,785.

The announcement stated that the highest repurchase price was HKD 10.5 per share and the lowest was HKD 9.69, with an aggregate amount of HKD 8,773,092 paid for the repurchase. The company’s authorized repurchase mandate covered up to 10,909,678 shares, and 3,422,600 shares have been repurchased under that mandate to date.